1. Home
  2. ARCT vs SLI Comparison

ARCT vs SLI Comparison

Compare ARCT & SLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • SLI
  • Stock Information
  • Founded
  • ARCT 2013
  • SLI 1998
  • Country
  • ARCT United States
  • SLI Canada
  • Employees
  • ARCT N/A
  • SLI N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • SLI Major Chemicals
  • Sector
  • ARCT Health Care
  • SLI Industrials
  • Exchange
  • ARCT Nasdaq
  • SLI Nasdaq
  • Market Cap
  • ARCT 487.0M
  • SLI 406.1M
  • IPO Year
  • ARCT N/A
  • SLI N/A
  • Fundamental
  • Price
  • ARCT $16.79
  • SLI $1.66
  • Analyst Decision
  • ARCT Strong Buy
  • SLI Strong Buy
  • Analyst Count
  • ARCT 7
  • SLI 2
  • Target Price
  • ARCT $65.00
  • SLI $3.95
  • AVG Volume (30 Days)
  • ARCT 400.9K
  • SLI 1.4M
  • Earning Date
  • ARCT 03-06-2025
  • SLI 02-06-2025
  • Dividend Yield
  • ARCT N/A
  • SLI N/A
  • EPS Growth
  • ARCT N/A
  • SLI N/A
  • EPS
  • ARCT N/A
  • SLI 0.61
  • Revenue
  • ARCT $160,399,000.00
  • SLI N/A
  • Revenue This Year
  • ARCT $7.33
  • SLI N/A
  • Revenue Next Year
  • ARCT $4.71
  • SLI N/A
  • P/E Ratio
  • ARCT N/A
  • SLI $2.74
  • Revenue Growth
  • ARCT N/A
  • SLI N/A
  • 52 Week Low
  • ARCT $14.30
  • SLI $1.05
  • 52 Week High
  • ARCT $45.00
  • SLI $2.64
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 46.15
  • SLI 53.86
  • Support Level
  • ARCT $16.07
  • SLI $1.46
  • Resistance Level
  • ARCT $17.95
  • SLI $1.76
  • Average True Range (ATR)
  • ARCT 1.36
  • SLI 0.11
  • MACD
  • ARCT -0.07
  • SLI 0.02
  • Stochastic Oscillator
  • ARCT 14.86
  • SLI 71.01

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About SLI Standard Lithium Ltd.

Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, Tetra Project, and Bristol Dry Lake Project.

Share on Social Networks: